Uncovering core stemness biomarkers in HBV-HCC through integrated multi-omics
Open Access
- 14 May 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (5) , e0349171
Abstract
Chronic hepatitis B virus (HBV) infection is a major etiology of hepatocellular carcinoma (HCC), with cancer stem cells (CSCs) playing a critical role in tumor progression and therapeutic resistance. However, the specific mechanisms linking HBV infection to stemness features in HBV-associated HCC (HBV-HCC) remain incompletely defined. To identify potential regulators, we conducted an integrated in silico multi-omics analysis using single-cell and bulk transcriptomic datasets. Comparative stemness scoring across major cell populations prioritized the endothelial compartment for further analysis. Subsequent pseudotime trajectory and CytoTRACE2 analysis of single-cell RNA sequencing (scRNA-seq) data identified Cluster 4 (C4) as a putative stemness-associated endothelial subpopulation, from which 21 differentially positive-HBV-expressed genes (DPEGs) were derived. In bulk RNA sequencing (bulk RNA-seq), weighted gene co-expression network analysis (WGCNA) identified genes strongly correlated with stemness in the blue module. Cross-referencing scRNA-seq and bulk RNA-seq yielded 52 shared genes. Random Forest feature selection prioritized two high-confidence biomarkers: SSR2 and UBE2D3 . A combined diagnostic model based on these two genes showed favorable performance across independent cohorts with bootstrap-supported validation, and survival analyses indicated that high SSR2 expression and low UBE2D3 expression were associated with poor clinical outcomes. Mechanistically, pathway activity correlation analyses revealed that SSR2 and UBE2D3 are significantly associated with endoplasmic reticulum stress (ERS), and mTOR signaling, suggesting a potential coordinated role in regulating viral persistence and stemness maintenance. Overall, our findings propose SSR2 and UBE2D3 as candidate diagnostic and prognostic biomarkers, providing a hypothesis-generating framework for developing targeted therapeutic strategies against HBV-HCC.Keywords
Funding Information
- NHC Key Laboratory of Nuclear Technology Medical Transformation (2024HYX001)
- Research and innovation Fund of Wuhan Asia General Hospital (2025KYCX1-B06)
- Open Project Fund of Hubei Key Laboratory of Embryonic Stem Cell Research (2025ESOF003)
- College Students' Innovative Entrepreneurial Training Plan Program of Hubei (S202410488176)
This publication has 66 references indexed in Scilit:
- PDX1 phosphorylation at S61 by mTORC1 links nutrient signaling to β cell function and metabolic diseaseCell Reports, 2026
- HMMR alleviates endoplasmic reticulum stress by promoting autophagolysosomal activity during endoplasmic reticulum stress‐driven hepatocellular carcinoma progressionCancer Communications, 2023
- Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapyCancer Communications, 2022
- Endoplasmic reticulum stress in liver diseasesHepatology, 2022
- Endoplasmic reticulum stress promotes HBV production by enhancing use of the autophagosome/multivesicular body axisHepatology, 2021
- Interaction of lncRNA‐MALAT1 and miR‐124 regulates HBx‐induced cancer stem cell properties in HepG2 through PI3K/Akt signalingJournal of Cellular Biochemistry, 2018
- Single‐cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinomaHepatology, 2018
- CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signalingHepatology, 2011
- Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored Polyubiquitin Chains in Innate ImmunityCell, 2010
- Activation of endoplasmic reticulum stress response by hepatitis viruses up‐regulates protein phosphatase 2A†Hepatology, 2007